Kosin Med J.  2018 Dec;33(3):289-296. 10.7180/kmj.2018.33.3.289.

Analysis of factors related systemic recurrence after breast conserving surgery in stage I breast cancer

• Kim YS
• Ryu DW
• Lee CH

• KMID: 2442539
• DOI: http://doi.org/10.7180/kmj.2018.33.3.289

Abstract

OBJECTIVES
In these days, patients with stage I breast cancer have increased by regular health examination and diagnostic tool development. The aim of this retrospective study is to identify systemic recurrence related factors after breast conserving surgery (BCS) for stage I breast cancer.
METHODS
In this study, we analyzed the correlation between systemic recurrence and pathologic factors. We reviewed 223 patients who underwent BCS for stage I breast cancer. Postoperative pathologic factors, recurrent rates and sites were studied. In addition, preoperative patients'data were also collected. Statistical analysis was done by using PASW 16.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Systemic recurrence was found in 16 patients (7.17%) within 5 years after primary surgery. 5 patients had lymphatic invasion and 6 patients had vascular invasion. Lymphatic and vascular invasion had statistical correlation with systemic recurrence (P = 0.004, P = 0.001).
CONCLUSIONS
In this retrospective study, we can conclude that vascular invasion and lymphatic invasion are related systemic recurrence after BCS for stage I patients. Further studies with large cohort will be required to fully understand the risk factors of systemic recurrence for stage I breast cancer patients.

Keyword

Breast neoplasms; Recurrence; Risk factors

MeSH Terms

Breast Neoplasms*
Breast*
Cohort Studies
Humans
Mastectomy, Segmental*
Recurrence*
Retrospective Studies
Risk Factors

Reference

1. Lee JB, Kim DH, Min BW, Ryu KW, Um JW, Kim AR, et al. Factors influencing the recurrence of breast cancer following modified radical mastectomy. J Korean Breast Cancer Soc. 2001; 4:128–135.

2. Park KH, Kim SI, Ko SS, Park BW, Lee KS. The pattern of systemic failure and factors influencing on the outcome after distant metastasis in breast cancer. J Korean Breast Cancer Soc. 2003; 6:109–116.

3. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006; 24:5652–5657.

4. Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res. 2006; 8:R62.

5. Lee HS, Kwak BS, Son BH, Ahn SH. Prognostic factors influence on the systemic recurrence in axillary lymph node negative breast cancer. J Korean Surg Soc. 2009; 77:238–245.

6. Kang SH, Chung KY, Kim YS, Kim JH. Disease free survival and prognostic factors for patients with breast conserving surgery. J Korean Surg Soc. 2004; 67:274–278.

7. Paik NS, Noh WC, Bang HY, Hwang DY, Choi DW, Lee JI, et al. Recurrence following breast conserving therapy. J Korean Breast Cancer Soc. 2000; 3:64–75.

8. Yi OV, Lee JW, Kim HJ, Lim WS, Park EH, LEE JS, et al. Risk factors of local recurrence after breast conserving therapy in invasive breast cancer. J Breast Cancer. 2009; 12:302–308.

9. Kute TE, Russell GB, Zbieranski N, Long R, Johnston S, Williams H, et al. Prognostic markers in node-negative breast cancer: a prospective study. Cytometry B Clin Cytom. 2004; 59:24–31.

10. Brenin DR, Manasseh DM, El-Tamer M, Troxel A, Schnabel F, Ditkoff BA, et al. Factors correlating with lymph node metastases in patients with T1 breast cancer. Ann Surg oncol. 2001; 8:432–437.

11. Kuru B, Camlibel M, Gulcelik MA, Alagol H. Prognostic factors affecting survival and disease-free survival in lymph node-negative breast carcinomas. J Surg Oncol. 2003; 83:167–172.

12. Tanis E, van de Velde CJ, Bartelink H, van de Vijver MJ, Putter H, van der Hage JA. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer. Eur J Cancer. 2012; 48:1751–1756.

13. Kim SI, Park BW, Lee KS. The impact of Patient age upon locoregional and systemic failures after breast conservation therapy: comparison of the results from the groups above and below 35 years. J Korean Breast Cancer Soc. 2001; 4:68–73.

14. Park SH, Kim SI, Park BW, Lee KS. Prognostic factors in axillary lymph node negative breast cancer. J Korean Breast Cancer Soc. 2004; 7:111–120.

15. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol. 2009; 27:2466–2473.

16. Van der Hage JA, Putter H, Bonnema J, Bartelink H, Therasse P, Van de Velde CJ, et al. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer. 2003; 39:2192–2199.

17. Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999; 43:25–38.

18. Kang HS, Noh DY, Youn YK, Oh SK, Choe KJ. The predictors of axillary node metastasis in 2cm or less breast cancer univariate and multivariate analysis. J Korean Breast Cancer Soc. 1999; 2:7–13.

19. Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, et al. Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009; 73:357–364.

20. Son BH, Ahn SH, Kwak BS, Kim JK, Kim HJ, Hong SJ, et al. The recurrence rate, risk factors and recurrence patterns after surgery in 3700 patients with operable breast cancer. J Breast Cancer. 2006; 9:134–144.

21. Albert JM, Gonzalez-angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, et al. Estrogen/progesterone receptor negativity and her2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer. Int J Radiat Oncol Biol Phys. 2010; 77:1296–1302.

22. Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007; 9:R6.

23. Choi NK, Kim SY, Kim TY, Chae MK, Baek MJ, Lim CW, et al. Clinical correlation of c-erbB-2, p53, bcl-2, and c-myc expression in patients with breast cancer. J Korean Surg Soc. 2002; 62:371–380.

24. Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999; 43:25–38.

25. Noh JM, Choi DH, Huh SJ, Park W, Yang JH, Nam SJ, et al. Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype. J Breast Cancer. 2011; 14:46–51.